See how parallel CMC workstreams can help accelerate the path from DNA to IND.
Getting an antibody program from DNA to IND quickly requires more than compressing individual development steps.
See how platform technologies, parallel CMC workstreams, and phase-appropriate development strategies can work together to shorten timelines while maintaining product quality, scientific rigor, and regulatory alignment.
